Inside 340B Report podcast

Episode 49: 340B Rebate Challenged, Midterms Preview, Amgen's Data Reqs Under Fire

0:00
29:16
15 Sekunden vorwärts
15 Sekunden vorwärts

In this episode, 340B Report Publisher and CEO Ted Slafsky joins Editor-in-Chief Will Newton, Managing Editor Shannon Young and National Correspondent Luke Zarzecki in breaking down the latest 340B news, including legal challenges and legislation that aim to stop the Trump administration's 340B rebate model pilot from taking effect in January. They also discuss the upcoming midterm elections, and what they could mean for 340B policy; a U.S. House Democrat priorities memo that includes 340B-related actions; and the controversy surrounding Amgen's new healthcare encounter and services claims data requirements.

Key Topics Covered:

Actions to Halt the 340B Rebate Model Pilot 

Will breaks down the American Hospital Association (AHA)-led lawsuit seeking to block the Health Resources and Services Administration's (HRSA) 340B rebate pilot from taking effect on Jan. 1. He also discusses a federal judge's recent order allowing drug manufacturers to join the case as intervenors to defend the pilot. Meanwhile, Luke details the newly unveiled 340B Rebate Model Delay Act, a U.S. House bill which would delay the Trump administration's 340B rebate model pilot, or "any substantially similar" rebate program until Dec. 31, 2028.

Midterm Elections 

Shannon and Ted preview how the Nov. 3 midterm elections could affect 340B policy. Shannon notes the lawmakers up for reelection who serve on the U.S. House and Senate committees overseeing 340B—and who could be tapped to lead those panels depending on the election outcomes. Ted breaks down how election analysts expect the midterms to go for each party and how a close U.S. Senate race in Kansas could affect 340B policy on Capitol Hill in the next Congress. Shannon also discusses U.S. House Democrats' top healthcare priorities for the 120th Congress, including a September letter lawmakers sent to House Minority Leader Hakeem Jeffries (D-N.Y.) that called for immediate actions to bolster the 340B program and halt the Trump administration's 340B rebate model pilot.

Amgen's New Requirements 

Will details Amgen's new healthcare visit and service claims data requirements set to take effect in mid-November and explains why those requirements are more expansive than other drugmaker policies. Additionally, Luke discusses the National Association of Community Health Centers' letter asking HRSA to review the policy and direct Amgen to halt the requirements before they take effect next month.

340B Report's Midterm Webinar 

Ted previews 340B Report's Nov. 10 subscriber-only webinar, which will dive into the midterm election results and what they mean for state and federal 340B policy in 2027 and beyond. He notes that the editorial team will also break down the major 340B changes on the horizon, including the latest news on the 340B rebate model and its legal challenges. Subscribers can learn more and register for the webinar by logging into 340B Report. Prospective subscribers can learn more about this exciting event by visiting 340B Report and taking advantage of a 25% discount on subscriptions. They can then benefit from all our must-watch webinars and other valuable services available only to subscribers.

Subscribe & Stay Updated

How to Follow Us and Learn More About This Episode's Sponsor

Stay tuned for more episodes every other week! 🎧Subscribe to Inside 340B Report on your favorite podcast platform or YouTube.

This episode is brought to you by one of our great Ultra Diamond sponsors, Verity Solutions. Verity Solutions' innovative, award-winning 340B program management solutions are designed to optimize 340B pharmacy spend and maximize pharmacy supply chain savings. We are very grateful to Verity Solutions for its sponsorship.

Subscribe to 340B Report with a Special Discount

We're offering a special discount for podcast listeners. 340B Report is the indispensable source for news and intelligence on the 340B program. First-time subscribers may subscribe now using coupon code PODCAST25. Not ready to subscribe? Sign up for a 15-day free trial.

Weitere Episoden von „Inside 340B Report“